Jyoti

Traceable AI Secures $30M Strategic Investment Round

Retrieved on: 
星期三, 五月 1, 2024

Traceable AI , the industry's leading API security company, today announced a $30 million strategic investment from a group of investors, including Citi Ventures - the venture arm of Citigroup, lead investor IVP, Geodesic Capital, Sorenson Capital, and Unusual Ventures.

Key Points: 
  • Traceable AI , the industry's leading API security company, today announced a $30 million strategic investment from a group of investors, including Citi Ventures - the venture arm of Citigroup, lead investor IVP, Geodesic Capital, Sorenson Capital, and Unusual Ventures.
  • This strategic investment highlights the growing recognition of API security as a critical challenge for enterprises across industries, particularly within the heavily-regulated financial sector.
  • “Traceable has set the benchmark for API security across a wide range of enterprises, including financial institutions, healthcare providers, retail giants, and global telecom providers.
  • "The recent attention Traceable has received from enterprise customers, security practitioners, and investors alike underscores that organizations understand the strategic importance of API security.

SimBioSys® Elevates Leadership Team as It Receives First FDA Clearance for Digital Precision Medicine Platform, TumorSight™

Retrieved on: 
星期五, 一月 5, 2024

The announcement coincides with the company's landmark achievement of receiving FDA clearance for its groundbreaking TumorSight™ platform.

Key Points: 
  • The announcement coincides with the company's landmark achievement of receiving FDA clearance for its groundbreaking TumorSight™ platform.
  • A distinguished HealthTech executive, Palaniappan brings a wealth of experience from notable roles at Abbott, Thermo Fisher Scientific, and McKinsey.
  • Tushar Pandey, Chief Executive Officer of SimBioSys, expressed enthusiasm about Palaniappan's appointment, stating, “We are thrilled to welcome Jyoti to the SimBioSys team.
  • The recent FDA clearance is just the beginning, and I look forward to collaborating with Tushar and the SimBioSys team to accelerate our strategy and boldly advance the future of precision medicine in oncology to deliver better outcomes for patients.”

Mark Biznek appointed Chief Operations Officer of Ballard Power Systems

Retrieved on: 
星期一, 一月 9, 2023

VANCOUVER, BC, Jan. 9, 2023 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the appointment of Mark Biznek, MEng, as Chief Operating Officer (COO), effective immediately.

Key Points: 
  • VANCOUVER, BC, Jan. 9, 2023 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the appointment of Mark Biznek, MEng, as Chief Operating Officer (COO), effective immediately.
  • Mark brings a breadth of experience during a 30-year career in operations, manufacturing, business development and manufacturing engineering.
  • During the past 10 years, Mark served in various leadership roles for Kohler Power Systems, including as General Manager of Marine & Power Solutions, as Vice President of Global Operations & Supply Chain, and as Vice President of Operations & Engine Development.
  • "With Mark's appointment, Jyoti Sidhu, previously serving in the joint leadership role of Senior Vice President, Chief People Officer and Senior Vice President, Operations, will fully transition to the role of Senior Vice President, Chief People Officer.

Jyoti Mundra, PhD, appointed as new Chief Business Officer at MEDSIR

Retrieved on: 
星期四, 九月 22, 2022

BARCELONA, Spain, Sept. 22, 2022 /PRNewswire/ -- MEDSIR , an international company specialized in the strategic design of clinical trials is pleased to announcethe appointment of Jyoti Mundra, PhD, as Chief Business Officer.

Key Points: 
  • BARCELONA, Spain, Sept. 22, 2022 /PRNewswire/ -- MEDSIR , an international company specialized in the strategic design of clinical trials is pleased to announcethe appointment of Jyoti Mundra, PhD, as Chief Business Officer.
  • In her role, Jyoti will help accelerate the growth of MEDSIR while enhancing MEDSIR's presence and business in North America.
  • She will be leading global business and marketing team to provide clinical solutions to biopharma companies and build a network with hospitals and institutions.
  • Prior to joining MEDSIR , Jyoti served as a Director of Business Development at Sinclair Research and helped achieve hypergrowth leading to an acquisition by Altasciences.

Harness Valuation Soars to $3.7 Billion With $230 Million in Series D Funding

Retrieved on: 
星期二, 四月 26, 2022

SAN FRANCISCO, April 26, 2022 /PRNewswire/ -- Harness, the modern software delivery platform company, today announced it has closed $230 million in new financing at a valuation of $3.7 billion, more than doubling its valuation since its last financing round in January 2021. Norwest Venture Partners led the Series D round, with new investors J.P. Morgan, Capital One Ventures, Splunk Ventures, Adage Capital Partners, Balyasny Asset Management, Gaingels, Harmonic Growth Partners and all existing investors participating, including ServiceNow, Menlo Ventures, IVP, Unusual Ventures, Citi Ventures, Battery Ventures, Alkeon Capital, GV (formerly Google Ventures), Sorenson Capital, Thomvest Ventures and Silicon Valley Bank. The round includes $175 million in equity and $55 million in debt financing. Harness will use the new funding infusion to continue to grow its world-class talent across the company and further expand the Harness Software Delivery Platform.

Key Points: 
  • The round includes $175 million in equity and $55 million in debt financing.
  • Harness will use the new funding infusion to continue to grow its world-class talent across the company and further expand the Harness Software Delivery Platform.
  • "Today's milestone funding round and Harness's rapidly rising valuation is only possible because of our incredible, delighted customers," said Jyoti Bansal, Harness CEO and cofounder.
  • We are excited to double down on our partnership with the world-class team at Harness as they build the Modern Software Delivery Platform."

JAGGAER Appoints Justin Sadler-Smith to Senior Vice President Europe

Retrieved on: 
星期二, 三月 1, 2022

JAGGAER has announced the immediate appointment of Justin-Sadler-Smith as its new Senior Vice President Sales, Europe.

Key Points: 
  • JAGGAER has announced the immediate appointment of Justin-Sadler-Smith as its new Senior Vice President Sales, Europe.
  • He will be replaced as Regional Vice President in Italy by Fabrizio Fassone, who joins from SAP.
  • JAGGAER CEO Jim Bureau commented, Justin did a phenomenal job of stabilizing, maturing and growing Northern Europe throughout 2021, all the time guided by his laser focus on customer success.
  • His consistent approach and strong leadership have given me the confidence to appoint Justin our leader across the entire continent of Europe.

Alio Announces Jyoti Palaniappan joins Board of Directors

Retrieved on: 
星期二, 二月 8, 2022

BROOMFIELD, Colo., Feb. 8, 2022 /PRNewswire/ -- Alio, a medical technology company reinventing the management of chronic disease,today announced Jyoti Palaniappan will join its Board of Directors as an Independent Director.

Key Points: 
  • BROOMFIELD, Colo., Feb. 8, 2022 /PRNewswire/ -- Alio, a medical technology company reinventing the management of chronic disease,today announced Jyoti Palaniappan will join its Board of Directors as an Independent Director.
  • Palaniappan will advise Alio on commercialization, product development, reimbursement, and market expansion.
  • Palaniappan brings to Alio decades of healthcare experience working for widely respected entities, such as, Abbott, Thermo Fisher Scientific and McKinsey.
  • "We are pleased to have an innovative leader like Jyoti join our Board of Directors," said Dave Kuraguntla, Alio's co-founder and CEO.

Fabric Genomics Appoints Industry Veteran Jyoti Palaniappan as Chief Commercial Officer

Retrieved on: 
星期三, 二月 2, 2022

Fabric Genomics, Inc., a leader in AI-based clinical decision support platforms for genomics-driven precision medicine, today announced the appointment of Jyoti Palaniappan to its executive leadership team in the role of Chief Commercial Officer.

Key Points: 
  • Fabric Genomics, Inc., a leader in AI-based clinical decision support platforms for genomics-driven precision medicine, today announced the appointment of Jyoti Palaniappan to its executive leadership team in the role of Chief Commercial Officer.
  • View the full release here: https://www.businesswire.com/news/home/20220202005224/en/
    Fabric Genomics, Inc., a leader in AI-based clinical decision support platforms for genomics-driven precision medicine, has appointed Jyoti Palaniappan to its executive leadership team in the role of Chief Commercial Officer.
  • (Photo: Business Wire)
    We are thrilled to welcome Jyoti to Fabric as we continue to scale our commercial organization, said Martin Reese, PhD, Co-founder and CEO of Fabric Genomics.
  • Before this, he served as Chief Commercial Officer for Bigfoot Biomedical, where he built all the foundational commercial capabilities for the innovative start-up.

ADVISOR GROUP PROFESSIONALS RECOGNIZED FOR EXCEPTIONAL CHARITABLE WORK BY INVEST IN OTHERS

Retrieved on: 
星期二, 十二月 14, 2021

Advisor Group recognized the advisors at the 10th annual ConnectED conference, a hybrid event held in October.

Key Points: 
  • Advisor Group recognized the advisors at the 10th annual ConnectED conference, a hybrid event held in October.
  • Advisor Group's network includes FSC Securities, Royal Alliance Associates, SagePoint Financial, Securities America, Triad Advisors and Woodbury Financial Services.
  • Kenneth Lawrence "Larry" Agee, a SagePoint advisor from Lake Charles, La.-based Agee Financial, received a $50,000 grant from IiO.
  • Greg Cornick, Advisor Group's President, Advice and Wealth Management, said, "We are pleased that the tireless dedication of Advisor Group's affiliated advisors has been recognized by the Invest in Others Charitable Foundation.